Fig. 3From: The significant role of redox system in myeloid leukemia: from pathogenesis to therapeutic applicationsMechanisms by which antioxidants counteract deleterious effects of pro-oxidant therapy. Antioxidant application to pro-oxidant therapy reduces OS, ROS signaling, and proliferative drive. Furthermore, it induces cell cycle suppression, increases tumor response of AML cells, and protects nonmalignant cellsBack to article page